📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
UTIAMC Appoints Vetri Subramaniam as MD & CEO Effective February 1, 2026
UTI Asset Management Company has announced a leadership transition as Mr. Imtaiyazur Rahman completes his tenure as MD & CEO on January 31, 2026. Mr. Vetri Subramaniam is set to take charge as the new Managing Director & Chief Executive Officer starting February 1, 2026. In conjunction with this change, the company has updated its list of Key Managerial Personnel (KMPs) authorized to determine the materiality of events under SEBI regulations. This transition represents a significant shift in the top leadership of one of India's prominent asset management firms.
Key Highlights
Mr. Imtaiyazur Rahman to complete his tenure as MD & CEO on January 31, 2026
Mr. Vetri Subramaniam to take charge as MD & CEO effective February 1, 2026
Revised KMP list for materiality determination includes the new CEO, CFO Vinay Lakhotia, and CS Arvind Patkar
Disclosure made in compliance with Regulation 30(5) of SEBI (LODR) Regulations, 2015
💼 Action for Investors
Investors should monitor the strategic direction and any potential changes in investment philosophy under the new leadership. No immediate portfolio action is required as this appears to be a planned leadership succession.
UTI AMC Q3 PAT Falls 20% to ₹121 Cr on VRS Costs; Core Revenue Up 7% in 9M FY26
UTI AMC reported a 20% YoY decline in Q3 FY26 PAT to ₹121 crore, largely due to one-time exceptional items of ₹109 crore related to a Voluntary Retirement Scheme (VRS). Despite the net profit dip, the core business remains resilient with 9M FY26 core revenue growing 7% YoY to ₹1,164 crore. Mutual Fund QAAUM grew 11.75% YoY to ₹3.94 lakh crore, though market share slightly moderated to 4.86%. The company continues to see strong traction in digital channels and SIP books, with SIP AUM rising 16.64% YoY.
Key Highlights
Q3 FY26 Consolidated PAT stood at ₹121 crore, down 20% YoY, impacted by ₹109 crore in exceptional VRS and pension-related costs.
UTI Mutual Fund QAAUM increased 11.75% YoY to ₹3,93,809 crore, while total Group AUM reached ₹23.15 lakh crore.
Core Revenue from sale of services for 9M FY26 grew by 7% YoY to ₹1,164 crore, indicating steady operational growth.
SIP AUM grew 16.64% YoY to ₹44,752 crore, with 93% of the SIP book having a tenure of more than 5 years.
Operating margins for 9M FY26 stood at 14 bps, while the company maintained a high digital sales contribution of 89.04%.
💼 Action for Investors
Investors should treat the PAT decline as a one-time event due to VRS costs and focus on the steady growth in core revenue and AUM. Watch for margin expansion in upcoming quarters as the benefits of reduced employee costs from the VRS program begin to materialize.
UTI AMC Q3 FY26: Group AUM Hits ₹23.15 Lakh Cr; 9M Normalised PAT Down 12% to ₹567 Cr
UTI AMC reported a 11.44% YoY growth in Total Group AUM to ₹23.15 lakh crore for 9M FY26, driven by steady growth in mutual funds and pension businesses. Consolidated PAT for 9M FY26 declined by 27% YoY to ₹471 crore, largely due to a ₹109 crore exceptional charge related to VRS ex-gratia and pension revisions. Excluding these one-time items, Normalised PAT stood at ₹567 crore, down 12% YoY. Despite profit pressure, the company saw its SIP AUM grow by 16.64% YoY to ₹44,752 crore, maintaining a strong 4.86% market share in MF QAAUM.
Key Highlights
Total Group AUM reached ₹23.15 lakh crore, with UTI MF QAAUM growing 11.75% YoY to ₹3,93,809 crore.
9M FY26 Consolidated PAT fell 27% YoY to ₹471 crore, impacted by a ₹109 crore exceptional item for VRS and labor code changes.
Core Revenue from Sale of Services grew 7% YoY to ₹1,164 crore for the nine-month period ended December 2025.
SIP AUM increased to ₹44,752 crore, with monthly gross SIP inflows reaching ₹819 crore in December 2025.
NPS AUM market share remains significant at 24.42%, while Passive AUM grew 17.41% YoY to ₹1,74,888 crore.
💼 Action for Investors
Investors should monitor if the recent VRS-related cost rationalization leads to improved operating margins in future quarters. While AUM growth remains healthy, the decline in normalized profits indicates ongoing pressure on yields and competitive intensity in the AMC sector.
UTI AMC Q3 Standalone Revenue Up 28% YoY; PAT Impacted by ₹108 Cr Exceptional VRS Charge
UTI Asset Management Company reported a standalone revenue of ₹423.12 crore for the quarter ended December 31, 2025, marking a 28.5% growth over the same period last year. However, Profit After Tax (PAT) for the quarter stood at ₹123.68 crore, down from ₹142.49 crore YoY, primarily due to a significant one-time exceptional expense. The company recognized a charge of ₹108.49 crore related to a Voluntary Retirement Scheme (VRS) and adjustments for New Labour Codes. Despite the bottom-line impact, core operational revenue showed strong momentum compared to both the previous quarter and the previous year.
Key Highlights
Standalone Revenue from operations grew 28.5% YoY to ₹423.12 crore from ₹329.13 crore.
Recognized a one-time exceptional item of ₹108.49 crore, including ₹104.28 crore for VRS and ₹4.21 crore for New Labour Codes.
Standalone PAT declined to ₹123.68 crore compared to ₹166.21 crore in the preceding quarter (Q2 FY26).
184 employees opted for the Voluntary Retirement Scheme, which is expected to optimize long-term employee costs.
Granted 5,48,522 stock options to eligible employees at a grant price of ₹1,145.20 per share.
💼 Action for Investors
Investors should view the decline in PAT as a temporary setback caused by a one-time restructuring cost that will likely improve operational efficiency in the long run. The strong double-digit growth in revenue from operations remains a positive indicator of the company's core business health.